| Primary |
| Multiple Myeloma |
32.9% |
| Non-hodgkin's Lymphoma |
13.2% |
| Drug Use For Unknown Indication |
7.9% |
| Angle Closure Glaucoma |
5.3% |
| Prostate Cancer |
5.3% |
| Testis Cancer |
5.3% |
| Asthma |
3.9% |
| Metastases To Lung |
3.9% |
| Enterobacter Bacteraemia |
2.6% |
| Gout |
2.6% |
| Pancytopenia |
2.6% |
| Proteus Infection |
2.6% |
| Streptococcal Bacteraemia |
2.6% |
| Acute Lymphocytic Leukaemia |
1.3% |
| Bone Disorder |
1.3% |
| Brain Neoplasm |
1.3% |
| Brain Oedema |
1.3% |
| Deep Vein Thrombosis |
1.3% |
| Hypertension |
1.3% |
| Leukopenia |
1.3% |
|
| Intestinal Ischaemia |
8.0% |
| Nausea |
8.0% |
| Pneumonia |
8.0% |
| Staphylococcal Infection |
8.0% |
| Thrombocytopenia |
8.0% |
| Vision Blurred |
8.0% |
| Visual Impairment |
8.0% |
| Arrhythmia |
4.0% |
| Blood Glucose Increased |
4.0% |
| Loss Of Consciousness |
4.0% |
| Muscular Weakness |
4.0% |
| Neuropathy Peripheral |
4.0% |
| Pyrexia |
4.0% |
| Skin Nodule |
4.0% |
| Strongyloidiasis |
4.0% |
| Treatment Noncompliance |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
4.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.3% |
| Multiple Myeloma |
26.3% |
| Mantle Cell Lymphoma |
8.3% |
| Non-hodgkin's Lymphoma |
7.2% |
| Prophylaxis |
4.8% |
| Chronic Lymphocytic Leukaemia |
3.2% |
| Pain |
3.1% |
| Acute Lymphocytic Leukaemia |
2.7% |
| Diffuse Large B-cell Lymphoma |
1.7% |
| Hypertension |
1.6% |
| Amyloidosis |
1.5% |
| Premedication |
1.4% |
| Waldenstrom's Macroglobulinaemia |
1.4% |
| Bone Pain |
1.1% |
| Diabetes Mellitus |
1.1% |
| Gastrointestinal Disorder |
1.1% |
| Constipation |
1.0% |
| General Anaesthesia |
0.9% |
| Breast Cancer |
0.7% |
| Lymphoma |
0.7% |
|
| Sepsis |
11.5% |
| Sternal Fracture |
7.7% |
| Thrombocytopenia |
7.7% |
| Pulmonary Embolism |
6.4% |
| Toxic Epidermal Necrolysis |
6.4% |
| White Blood Cell Count Decreased |
6.4% |
| Diarrhoea |
5.1% |
| Respiratory Failure |
5.1% |
| Somnolence |
5.1% |
| Death |
3.8% |
| Febrile Neutropenia |
3.8% |
| Psychotic Disorder |
3.8% |
| Renal Impairment |
3.8% |
| Sinusitis |
3.8% |
| Thrombosis |
3.8% |
| Vomiting |
3.8% |
| Weight Decreased |
3.8% |
| Aspergillosis |
2.6% |
| Blood Potassium Decreased |
2.6% |
| Cardiac Failure Congestive |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
44.3% |
| Multiple Myeloma |
8.2% |
| Prophylaxis |
6.4% |
| Non-small Cell Lung Cancer |
5.5% |
| Breast Cancer |
5.4% |
| Premedication |
3.7% |
| Pain |
3.4% |
| Prophylaxis Of Nausea And Vomiting |
3.0% |
| Hypertension |
2.6% |
| Colorectal Cancer |
2.4% |
| Acute Lymphocytic Leukaemia |
2.1% |
| Nausea |
2.0% |
| Constipation |
1.9% |
| Histiocytosis Haematophagic |
1.6% |
| Lymphohistiocytosis |
1.6% |
| Allergy Prophylaxis |
1.3% |
| Dyspepsia |
1.2% |
| Colorectal Cancer Metastatic |
1.1% |
| Diarrhoea |
1.1% |
| Mantle Cell Lymphoma |
1.1% |
|
| Pneumothorax |
14.1% |
| Vomiting |
11.9% |
| Pyrexia |
8.1% |
| Wheezing |
7.6% |
| White Blood Cell Count Decreased |
7.0% |
| Thrombocytopenia |
6.5% |
| Sepsis |
5.9% |
| Pulmonary Embolism |
4.9% |
| Neurotoxicity |
4.3% |
| Weight Decreased |
4.3% |
| Pneumonia |
3.2% |
| Renal Failure Acute |
3.2% |
| Death |
2.7% |
| Haematotoxicity |
2.7% |
| Renal Failure |
2.7% |
| Febrile Neutropenia |
2.2% |
| Respiratory Failure |
2.2% |
| Tachycardia |
2.2% |
| Tooth Extraction |
2.2% |
| Tumour Lysis Syndrome |
2.2% |
|
